IFNAR1 and infection: Similarly, virus-specific CD8+ T cells in IFNAR1 KO mice treated with and without anti-PD-L1 monoclonal antibody in the subacute (from day 15) or chronic (from day 24) phase of LCMV-Arm infection, also demonstrated a reduced expression of effector cytokines (Figure S2).